This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Thursday, October 21, 2010
Hepatitis C Genotype 1-Predictors of Early Treatment Discontinuation/Video
Dr. Lauren Beste discusses her manuscript
"Predictors of Early Treatment Discontinuation Among Patients with Genotype 1 Hepatitis C and Implications for Viral Eradication."
No comments:
Post a Comment